Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
After a rough 2025, Optum Health is back on track. CEO Krista Nelson shared at the Wells Fargo Healthcare Conference that clinical metrics are outperforming expectations, driven by better care coordination, cost management, and operational efficiency. The company is eyeing margin expansion in 2027 and 2028, with top-line growth taking a back seat next year.
After a turbulent 2025 that sent UnitedHealth Group's shares tumbling, Optum Health is making a visible comeback. CEO Krista Nelson took the stage at the Wells Fargo Healthcare Conference to detail the turnaround strategy — and the news is largely positive. Clinical metrics are beating expectations, with notable improvements in transitions of care, care coordination, and patient support across skilled nursing facility admissions, inpatient readmissions, and length of stay.
Cost management has become a central theme for 2026, with Optum ramping up physician productivity and scheduling efficiency. The company also dug into its payer contracts to close misalignment gaps, with the "vast majority" of addressable 2027 contracts already addressed. On the strategic side, Optum plans to sell its interest in certain Florida clinics to private equity firm TPG — though Nelson was clear the company isn't exiting the Sunshine State.
By the Numbers:
Why it matters: Optum Health's recovery has broad implications for Medicare Advantage beneficiaries and the wider managed care landscape. How the nation's largest health services company navigates cost pressures and care quality will set a benchmark for the industry.
